Company profile
ResMed Inc.
NYSE: RMD · Healthcare · Medical - Devices
#60 of 1,422 Healthcare companies by revenue55th-percentile growth
EA Score
88AFH 91DQ 90GM 71SS 95
v0.1 · 65/100 weight · provisional
↑ market scale, filing timeliness · ↓ revenue growth (YoY), 3-yr revenue growth
Methodology →Revenue TTM
$5.5B
Rev growth YoY (TTM)
+10.3%
Net income (FY)
$1.4B
Employees
10,600
as of 2026-08-05
Market cap
$32.4B
as of 2026-08-05
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$5.1B$5.1B2025
Net income$1.4B$1.4B2025
Operating income$1.7B$1.7B2025
Total assets$8.2B$8.2B2025
Liabilities$2.2B$2.2B2025
Equity$6.0B$6.0B2025
Revenue trend
FY2019 – FY2025 · USD
FY19
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2024
By product
Sleep And Respiratory88%
Software As Service12%
By geography
U [S]64%
Global36%
The read
What is ResMed Inc.’s revenue?
ResMed Inc. booked $5.1B in FY2025 revenue, growing 9.8% year over year — about the middle of the pack among Healthcare companies we track, at a 27.2% net margin.
Peers · Healthcare
Select Medical Holdings Corporation74BBeOne Medicines AG75B+PACS Group, Inc.53DIncyte Corporation90ABausch + Lomb Corporation67BThe Ensign Group, Inc.80B+Neighbors
San Diego →Key facts
CEOMichael J. Farrell
SectorHealthcare
IndustryMedical - Devices
HeadquartersSan Diego, CA
ExchangeNYSE: RMD
Employees10,600
IPO date1995-06-02
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.